Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Although drug regulatory officials from South Korea, Japan and China met in Beijing for two days from Dec. 17 in their second tri-party meeting, they failed to report "noticeable progress" in their pursuit of an integrated clinical trial data-sharing program and mutual acceptance of their rules and guidelines, according to Korea FDA

You may also be interested in...

China Enhances Data Management, Communication For IND Approvals

The Center for Drug Evaluation is making headway to improve the IND process, but it is still a long road ahead.

Japan's PMDA Assesses Ethnic Factors On Clinical Data For Regional Trials – APEC Workshop

Asia Playing A More Important Role In Global Clinical Trials: World Pharma Trials Asia

SHANGHAI - With big pharmaceutical firms increasing their focus on emerging markets, more and more trials are now being conducted across Asia, including China, India, Turkey and South Korea, speakers at World Pharma Trials Asia 2010 said Sept. 14 in Shanghai

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts